Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501)
Authors
Keywords
-
Journal
CANCER
Volume 119, Issue 20, Pages 3610-3618
Publisher
Wiley
Online
2013-08-13
DOI
10.1002/cncr.28270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
- (2012) Michel Bolla et al. LANCET
- Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy
- (2012) U W Tunn et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?
- (2011) Cyrille Bastide et al. BJU INTERNATIONAL
- The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
- (2011) Emmanuel S. Antonarakis et al. BJU INTERNATIONAL
- Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials
- (2011) Federica Cuppone et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents
- (2011) Emmanuel S. Antonarakis et al. CANCER
- Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
- (2011) Tanya B. Dorff et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
- (2010) Peter Iversen et al. BJU INTERNATIONAL
- Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
- (2009) Thomas Wiegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
- (2009) Ian M. Thompson et al. JOURNAL OF UROLOGY
- Duration of Androgen Suppression in the Treatment of Prostate Cancer
- (2009) Michel Bolla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
- (2008) Mack Roach et al. JOURNAL OF CLINICAL ONCOLOGY
- Kinetics of Serum Androgen Normalization and Factors Associated With Testosterone Reserve After Limited Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer
- (2008) James L. Gulley et al. JOURNAL OF UROLOGY
- Testosterone Recovery After Prolonged Androgen Suppression in Patients With Prostate Cancer
- (2008) Frederick H. Yoon et al. JOURNAL OF UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now